Recursion Pharmaceuticals, Inc. (RXRX) — DEF 14A Filings
All DEF 14A filings from Recursion Pharmaceuticals, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
- DEF 14A Filing — Apr 28, 2025
-
Recursion Pharmaceuticals, Inc. Files Definitive Proxy Statement
— Apr 23, 2024 Risk: low
RECURSION PHARMACEUTICALS, INC. (RXRX) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. Recursion Pharmaceuticals, Inc. filed a Definitive Prox
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX